Linked e-resources
Details
Table of Contents
Development of a Manufacturing Process for the Formation of a Nucleoside Drug Candidate
Development of Efficient Routes to Access C-Glycosides as SGLT-2 Inhibitors for the Treatment of Type 2 Diabetes
Synthetic Routes to Sofosbuvir
Synthetic Challenges in the Assembly of Macrocyclic HCV NS3/NS4A Protease Inhibitors: The Case of BILN 2061 and Its Analogs
Recent Progress in the Synthesis of Super-Statins
Development of Synthetic Routes to Dolutegravir
Story of Eribulin Mesylate: Development of the Longest Drug Synthesis.
Development of Efficient Routes to Access C-Glycosides as SGLT-2 Inhibitors for the Treatment of Type 2 Diabetes
Synthetic Routes to Sofosbuvir
Synthetic Challenges in the Assembly of Macrocyclic HCV NS3/NS4A Protease Inhibitors: The Case of BILN 2061 and Its Analogs
Recent Progress in the Synthesis of Super-Statins
Development of Synthetic Routes to Dolutegravir
Story of Eribulin Mesylate: Development of the Longest Drug Synthesis.